Cart
sales@molnova.com
AR-A014418
CAS No. 487021-52-3
AR-A014418( AR-AO 14418 | AR 0133418 | AR 014418 | GSK 3β inhibitor )
Catalog No. M14634 CAS No. 487021-52-3
A potent, specific ATP-competitive inhibitor of GSK-3β with Ki/IC50 of 38/104 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 48 | In Stock |
|
| 5MG | 43 | In Stock |
|
| 10MG | 50 | In Stock |
|
| 25MG | 86 | In Stock |
|
| 50MG | 154 | In Stock |
|
| 100MG | 268 | In Stock |
|
| 200MG | 347 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAR-A014418
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, specific ATP-competitive inhibitor of GSK-3β with Ki/IC50 of 38/104 nM.
-
DescriptionA potent, specific ATP-competitive inhibitor of GSK-3β with Ki/IC50 of 38/104 nM; shows no significantly inhibition on CDK2, CDK5 (IC50>100 uM) or 26 other kinases; inhibits tau phosphorylation at a GSK3-specific site (Ser-396) in cells and protects N2A neuroblastoma cells against cell death mediated by inhibition of PI3K/Akt pathway.
-
In Vitro——
-
In Vivo——
-
SynonymsAR-AO 14418 | AR 0133418 | AR 014418 | GSK 3β inhibitor
-
PathwayPI3K/Akt/mTOR signaling
-
TargetGSK-3
-
RecptorGSK-3β
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number487021-52-3
-
Formula Weight308.3131
-
Molecular FormulaC12H12N4O4S
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCOc1ccc(cc1)CNC(=O)Nc2ncc(s2)[N+](=O)[O-]
-
Chemical NameUrea, N-[(4-methoxyphenyl)methyl]-N'-(5-nitro-2-thiazolyl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bhat R, et al. J Biol Chem. 2003 Nov 14;278(46):45937-45.
2. Martins DF, et al. J Pain. 2011 Mar;12(3):315-22.
3. Mazzardo-Martins L, et al. Neuroscience. 2012 Dec 13;226:411-20.
molnova catalog
related products
-
GSK-3 Inhibitor XIII
GSK-3 Inhibitor XIII, an ATP-competitive GSK-3 inhibitor (Ki: 24 nM), can be used to study diabetes and obesity.
-
GSK-3β inhibitor 14
GSK-3β inhibitor 14 (1,5-Benzothiazepin-4(5H)-one, 2,3-dihydro-2-methyl-5-(phenylmethyl)-) is a weak GSK-3β inhibitor, IC50﹥ 100μM.
-
CCG 203769
CCG 203769 is a selective inhibitor of RGS4 with an IC50 of 17 nM for the RGS4-Gαo protein-protein interaction.
